HVPG-guided Laparoscopic Versus Endoscopic Therapy for Variceal Rebleeding in Portal Hypertension: A Multicenter Randomized Controlled Trial (CHESS1803)
Sponsor: Beijing 302 Hospital
Listed as NCT03783065, this NA trial focuses on Portal Hypertension and Variceal Rebleeding and remains ongoing. Sponsored by Beijing 302 Hospital, it has been updated 10 times since 2019, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Sep 2023 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jul 2023 — Sep 2023 [monthly]
Recruiting NA
-
Feb 2023 — Jul 2023 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Sep 2021 — Feb 2023 [monthly]
Recruiting NA
-
Jan 2021 — Sep 2021 [monthly]
Recruiting NA
-
May 2019 — Jan 2021 [monthly]
Recruiting NA
-
Feb 2019 — May 2019 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2019 — Feb 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Beijing 302 Hospital
- LanZhou University
- Nanfang Hospital, Southern Medical University
- Southern Medical University, China
- Xingtai People's Hospital
For direct contact, visit the study record on ClinicalTrials.gov .